共 95 条
- [1] Yusuf S(2004)Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Lancet 364 937-952
- [2] Hawken S(1998)Leitlinie: Koronare Herzkrankheit / Angina Pectoris Z Kardiol 87 907-911
- [3] Ounpuu S(2003)Gender differences in secondary prevention of coronary heart disease: reasons to worry or not? Scand J Prim Health Care 21 37-42
- [4] Meyer J(2005)Gender differences in the treatment and secondary prevention of CHD at population level Scand Cardiovasc J 39 327-333
- [5] Breithardt G(2007)Gender differences in aspirin use among adults with coronary heart disease in the United States J Gen Intern Med 22 55-61
- [6] Erbel R(2015)Sex disparities in post-acute myocardial infarction pharmacologic treatment initiation and adherence: problem for young women Circ Cardiovasc Qual Outcomes 8 586-592
- [7] Erdmann E(2016)Gender differences in coronary heart disease Heart 102 1142-1149
- [8] Gohlke H(2016)The gender gap in risk factor control: Effects of age and education on the control of cardiovascular risk factors in male and female coronary patients. The EUROASPIRE IV study by the European Society of Cardiology Int J Cardiol 209 284-290
- [9] Hanrath P(2001)Sex inequalities in ischaemic heart disease in general practice: cross sectional survey BMJ 322 832-3205
- [10] Nilsson P(2013)Persisting gender differences and attenuating age differences in cardiovascular drug use for prevention and treatment of coronary heart disease, 1998–2010 Eur Heart J 34 3198-S68